Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
Conditions
Hemophilia A
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arkansas Children's Hospital, Little Rock, Arkansas, United States
Stanford University, Palo Alto, California, United States
Rady Children's Hospital, San Diego, California, United States
Contact: Principal Investigator (Kelly Bush, MD)Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
Rush University Children's Hospital, Chicago, Illinois, United States
Indiana Hemophilia & Thrombosis Center, Indianapolis, Indiana, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Children's Hospital of Michigan, Detroit, Michigan, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Oklahoma Center for Bleeding and Clotting Disorders, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Osman Khan, MD)
Study leads
Meera Chitlur, MD
Principal Investigator
Wayne State University